Latest filing published 29 Jun 2026 for CalciMedica, Inc.. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sudarshan Hebbar discloses dealings in CalciMedica, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 16 May 2023 to 25 June 2026.
On the market, this insider has only ever bought: 4 purchases, €144k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant.
The median purchase comes to €24k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of +13.7%, with the price up in 100% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 29 June 2026, the filings show a share grant in CalciMedica, Inc. The latest purchase dates back some time: it was published 423 days ago, on 21 August 2025. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations